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Abstract: Salvia dugesii is an invasive plant in Yunnan, China. To tentatively explore its utilization, a systematic phytochemical 
investigation was carried out on this plant, which led to the isolation of five new neo-clerodane diterpenoids, dugesins C–G (1–5), 
together with six known ones. Their structures were determined by comprehensive NMR and MS spectroscopic analysis. It was 
noteworthy that the eleven isolates, composed of five different carbocyclic systems derived from the neo-clerodane diterpenoid 
skeleton, were reported from the same plant for the first time. The anti-feedantial, cytotoxic, and antiviral activities of the isolates 
were evaluated. Dugesin F (4) was tested to be a non-toxic antiviral compound against influenza virus FM1. 
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Introduction 
The problem caused by invasive species has become in-
creasingly important in recent years. Salvia dugesii Fernald is 
native to Mexico and was introduced to Yunnan province of 
China in late 1980s. Its rapid spread in the ecosystem as an 
invasive plant and has caused increasing threats to the local 
agricultural and horticultural systems.1 Clerodane diterpenoids, 
a type of characteristic secondary metabolites of Salvia species, 
have been reported frequently with diverse biological activities 
from different Salvia species distributed in Mexico and Central 
and South America.2–7 Previously chemical studied on the title 
plant afforded several neo-clerodane diterpenoids.8 With the 
aim of searching for useful metabolites from this invasive 
plant and continuing our systematic studies of Salvia species,8–
10 the chemical constituents of S. dugesii was investigated, and 
five new neo-clerodane diterpenoids (dugesins C–G, 1–5) 
were isolated together with six known ones: dugesins A and 
B,8 tilifodiolide,3 isosalvipuberulin,4 salviandulin E,5 and salvi-
faricin.11,12 In order to assess the potential usage of these iso-
lates, their cytotoxic, antifeedantial, and antiviral activities 
were evaluated. Dugesin F (4) was shown to be a non-toxic 
antiviral compound against influenza virus FM1. Reported 
herein were the isolation, structure, and bioactivity evaluation 
of these metabolites. 
 
Results and Discussion 
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The acetone extract of the aerial parts of S. dugesii was re-
peatedly chromatographed over silica gel, Lichroprep RP-18, 
and Sephadex LH-20 to afford five new neoclerodane diterpe-
noids (dugesins C–G, 1–5), and six known ones, dugesins A 
and B, tilifodiolide, isosalvipuberulin, salviandulin E, and 
salvifaricin. It was interesting that the eleven isolates, com-
posed of five different carbocyclic systems derived from the 
normal neo-clerodane diterpenoid skeleton, were reported 
from the same plant for the first time. It was also noteworthy 
that the skeleton of dugesins A and D, and salviandulin E, 
possessing a 6/7 carbocyclic systems derived from the normal 
neo-clerodane skeleton, respectively, was very rare in na-
ture.5,6,8,13,14 Dugesin C, possessing a spirocyclic carbocyclic 
system derived from the normal neo-clerodane skeleton, was 
the third example of natural metabolites with such a novel 
carbocyclic skeleton.15 The major constituent (content about 
0.2% in the dry plant sample) of S. dugesii, tilifodiolide, can 
be seen as the only tetraline-type diterpenoid of clerodanic 
origin in nature products up to now.3 In order to assess the 
potential usage of these isolates, their antifeedantial, cytotoxic, 
anti-malarial, and antiviral activities were evaluated, and 
dugesin F (4) was tested to be a non-toxic antiviral compound 
against influenza virus FM1. It was noteworthy that dugesins 
C and D, possessing a 6/7 carbocyclic system derived from the 
normal neo-clerodane skeleton, were two salvigenane diterpe-
noids which were very rare in nature.  
Dugesin C (1) was obtained as white amorphous powder, 
giving a molecular ion peak at m/z 338 in the EIMS spectrum. 
It was deduced to have a molecular formula C20H18O5 by 
HRESIMS and the 13C NMR spectrum (Table 1). The IR spec-
trum showed the presence of furan ring (1504 and 874 cm−1) 
and α,β-unsaturated γ-lactone moieties (1754 and 1682cm-1).2–8 
The 13C NMR and DEPT spectra of 1 exhibited signals for 20 
carbons, including two lactonic carbonyls, six quaternary car-
bons, six methines (including four unsaturated ones and an 
oxygenated one), and six methylenes (one unsaturated one and 
one oxygenated). Considering many neo-clerodane diterpe-
noids have been isolated from different Salvia species previ-
ously, along with the spectral features obseverd in the NMR 
spectra, 1 could be ascribed to be a neo-clerodane diterpenoid. 
3–8,15 Carefully analysis of the NMR spectral data indicated that 
the 1D NMR data (Table 1) of 1 are very similar to those of 
salvileucalin A, a novel spirocyclic diterpenoid with a 
rearranged neo-clerodane keleton from Salvia leucantha.15 The 
differences observed in the 1H and 13C NMR spectra were the 
presence of one methylene (δC 23.5, C-2) and a methine (δC 
44.6, C-5) signals in 1 instead of the signals for the 
unsaturated methine at C-2 and the unsaturated quaternary 
carbon at C-5 in salvileucalin A. These differences suggested 
that the two double bonds of Δ2(3) and Δ4(5) in salvileucalin A 
was replaced by Δ3(4) in 1, which can be confirmed by the 
HMBC correlations from H-20 (H 5.16 and 5.10, each 1H) to 
C-1, C-9, C-10, and C-11, from H-3 (H 6.73, s) to C-1, C-2, 
C-5, and C-18, and from H-5 (H 3.16, m) to C-1, C-4, C-6, C-
9, C-10, and C-19. In addition, two key correlation systems of 
H-1/H-2/H-3 and H-5/H-19 in the 1H-1H COSY spectrum was 
evident in 1, which also confirm its major difference between 
salvileucalin A. 
The relative configuration of 1 was elucidated to be the 
same with that of salvileucalin A by analysis of ROESY spec-
trum (Figure 1). The ROESY cross-peaks of H-5/H-6β, H-
5/H-1β, H-19/H-20, and H-19/H-6α, established the β-
orientation of H-5 and C-6. H-12 was deduced to be α-oriented 
by its NOE correlation with H-20. On the basis of all the 
above evidence, the structure of 1 was established and named 
dugesin C. 
The HRESIMS indicated that 2 (dugesin D) has a molecular 
formula of C20H20O6. Spectroscopic data interpretation indicat-
ed that the structure of 2 was also closely similar to dugesin 
A.8 The differences in the 1D NMR spectral data of 2 com-
pared to dugesin A were the presence of three more methines 
(including a oxygenated one) instead of two olefinic carbons 
(C-9 and C-10) and a methylene signal (C-6) in dugesin A, 
which indicated C-9 and C-10 were two saturated methines 
and C-6 was substituted by a hydroxyl group. This deduction 
can be confirmed by HMBC correlations observed from H-6 to 
C-4, C-5, C-8, and C-10, from H-10 to C-1, C-5, C-9, C-19, 
and C-20, and from H-9 to C-1, C-5, C-8, C-10, C-11, C-12, 
and C-20. The relative configuration of 2 was established on 
the basis of ROESY experiment. The NOE correlations of H-
19 with Me-20 and H-6 indicated the α-orientation of both H-6 
and Me-20. In addition, the NOE correlations for H-9/H-10 
and H-9/H-12 indicated that H-10 and H-12 were both β-
oriented. So, the structure of 2 can be described as 6β-
hydroxy-3,8-salvigenadiene, and named dugesin D. 
Table 1. 13C NMR spectroscopic data for compounds 1-5 (100 
MHz; δ in ppm). 
Pos. 1a 2b 3a 4c 5a
1 30.0 CH2 28.3 CH2 19.9 CH2 126.2 CH 20.1 CH2 
2 23.5 CH2 26.1 CH2 27.2 CH2 128.7 CH 26.7 CH2 
3 136.3 CH 138.9 CH 138.9 CH 137.1 CH 136.8 CH 
4 127.3 C 137.2 C 134.7 C 132.0 C 136.0 C 
5 38.5 C 54.9 C 49.4 C 60.5 C 43.7 C 
6 35.1 CH2 67.4 CH 68.8 CH 44.3 CH2 36.4 CH2 
7 17.2 CH2 29.5 CH2 24.0 CH2 208.4 C 141.4 CH 
8 126.7 C 123.8 C 42.9 CH 49.4 CH 135.8 C 
9 135.9 C 38.9 CH 36.6 C 60.5 C 40.0 C 
10 44.6 CH 35.7 CH 46.6 CH 46.3 CH 44.8 CH 
11 156.4 C 167.6 C 43.4 CH2 43.8 CH2 46.0 CH2 
12 74.3 CH 77.3 CH 70.0 CH 74.5 CH 193.9 C 
13 121.1 C 121.3 C 124.3 C 130.5 C 128.6 C 
14 107.6 CH 109.1 CH 108.4 CH 110.5 CH 108.5 CH 
15 144.6 CH 144.9 CH 144.0 CH 144.2 CH 147.4 CH 
16 141.8 CH 142.7 CH 139.6 CH 140.7 CH 144.3 CH 
17 171.9 C 174.8 C 172.8 C 9.7 CH3 170.3 C 
18 169.3 C 169.4 C 167.1 C 168.6 C 168.9 C 
19 67.0 CH2 71.1 CH2 70.8 CH2 76.5 CH2 72.4 CH2 
C20 118.5 CH2 15.1 CH3 19.0 CH3 98.9 CH 22.0 CH3 
CH3CO   169.3 C   
CH3CO   20.9 CH3   
arecorded in CDCl3; brecorded in C5D5N; Crecorded in acetone-d6. 
 
Figure 1.  Key ROESY correlations for dugesin C (1). 
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The molecular formula of dugesin E (3) was determined to 
be C22H24O7 from its HRESIMS and NMR spectral data. The 
13C NMR spectrum (Table 1) exhibited signals for seven qua-
ternary carbons, eight methines, five methylenes, and two me-
thyls. A side-by-side comparison of the 1D NMR spectral data 
of 3 and bacchotricuneatin A showed that 3 was the acetoxyl 
derivative of bacchotricuneatin A.16 The acetoxyl group was 
located at C-6 by the HMBC correlations observed between H-
6 (H 5.33, s) with C-4, C-5, C-8, C-19, and the acetoxyl car-
bonyl at δC 169.3 (s). The relative configuration of 3 was sug-
gested to be the same as that of bacchotricuneatin A by the 
analysis of the ROESY correlations (Figure 2). The NOE cor-
relation between H-6 and H-19 indicated the α-orientation of 
H-6. In the same spectrum, the correlations for H-8/H-12, H-
8/H-10, Me-20/H-19, and H-1α/H-19 confirmed H-8, H-10, 
and H-12 were all β-oriented while Me-20 was in the α-
orientation. Thus, the structure of 3 was elucidated and the 
trivial name was proposed as dugesin E. 
Dugesin F (4) has the molecular formula C20H20O6 deduced 
from the HRESIMS. The NMR spectral data of 4 were closely 
comparable to those of salvifolin except for the lack of an ace-
tyl group at C-20,3 which indicated that compound 4 was the 
20-deacetyl derivative of salvifolin. This deduction can be 
confirmed by the HMBC correlations from H-20 to C-8, C-9, 
C-10, C-11, and C-12. The relative configuration of 4 was 
indicated to be the same as that of salvifolin by the compara-
tive analysis of the ROESY spectrum (Figure 3). The NOE 
correlations for H-10/H-6β, H-10/H-8, H-6β/H-8, and H-20/H-
19 observed in the ROESY spectrum indicated the β-
orientation of H-8, H-10, and H-20. The configuration of H-12 
was α-oriented as indicated by the NOE correlation of Me-
17/H-12. On this basis, the structure of 4 was determined and 
named dugesin F. 
The molecular formula C20H20O6 was determined for 
dugesin G (5) by the HRESIMS. The 1H and 13C NMR signals 
for one tertiary methyl, a β-substituted furan ring, an carboxyl, 
and an α,β-unsaturated γ-lactone moieties were evident. Care-
fully spectroscopic data interpretation indicated that the struc-
ture of 5 was very similar to nasimalun A, a neo-clerodane 
diterpenoid previously isolated from Barringtonia racemosa.17 
 
Figure 3.  Key ROESY correlations for dugesin F (4). 
Table 2. 1H NMR spectroscopic data for 1-5 (400 MHz; δ in ppm, J in Hz). 





1.35 m 1.22 m 
1.76 m 
6.40 m 1.23 m 
1.84 m 
2a 2.40 m 2.13 m 2.40 m 6.50 m 2.40 m 
2b 1.90 m  2.21 m  2.11 m 
3 6.73 s 7.07 s 6.84 d (6.1) 6.97 d (5.0) 6.83 d (6.0) 
5 3.16 m     
6 1.89 m 4.45 d (3.5) 5.33 s 2.07 m 2.55 dd (6.3, 18.3)
6β 1.70 m  2.62 m 2.19 d (18.3)
7a 2.50 m 3.40 dd (3.5, 17.4) 2.21 m  7.22 d (6.3) 
7b  3.13 d (17.4)    
8   2.96 dd (6.5, 9.8) 3.04 m  
9  2.67 dd (7.3, 9.2)    
10 3.16 m 3.31 m 2.39 m 3.26 m 2.61 m 
11a   2.20 m  2.83 dd (8.1, 13.2) 3.72 d (16.3) 
11b   1.93 m 2.21 dd (8.1, 13.2) 2.61 d (16.3) 
12 6.01 s 6.01 s 5.44 m 5.18 t (8.1)  
14 6.09 s 6.44 s 6.41 s 6.54 s 6.66 s 
15 7.36 s 7.66 s 7.42 s 7.44 s 7.98 s 
16 7.51 s 7.92 s 7.46 s 7.50 s 7.36 s 
17    1.13 d (7.0)  
19a 4.29 t (9.2) 4.31 d (8.8) 4.15 d (8.6) 4.13 d (9.1) 3.99 s 
19b 4.51 t (9.2) 3.13 d (8.8) 4.01 d (8.6) 4.47 d (9.1)  
20a 5.16 s 0.72 d (7.3) 0.83 s 5.16 s 1.12 s 
20b 5.10 s     
CH3CO   2.02 s   
arecorded in CDCl3; brecorded in C5D5N; crecorded in acetone-d6. 
 
Figure 2.  Key ROESY correlations for dugesin E (3). 
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It was evident that signals for the methoxyl group in nasimalun 
A was absent in the 1D NMR spectra of 5. The other notable 
difference was that the oxygenated methine (C-8) and a meth-
ylene (C-7) in nasimalun A were changed into a double bond 
in 5. This was supported by HMBC correlations from H-7 to 
C-5, C-6, C-8, C-9, and C-17. In the ROESY spectrum, the 
correlations of Me-20/H-19, H-19/H-1α, H-1β/H-10 can be 
found, which indicated Me-20 was in the α-orientation while 
H-10 was β-oriented. Then, the structure of 5 (dugesin G) was 
thus established as depicted. 
To explore the usage of this invasive plant, metabolites of 
this plant had been assessed in human tumor cell lines as well 
as in influenza virus FM1 strain. Firstly, the eleven isolates 
were evaluated for cytotoxicity toward human tumor cells 
HepG2, CNE, Hela, and NCI-H460, but none of them exhibit-
ed promising antitumor activity with IC50 < 20 µM. In antiviral 
assay, sample were tested in vitro anti-influenza ability by 
Cytopathic effect (CPE) and hemagglutination (HI) test. Under 
their non-toxic concentrations to dog kidney MDCK cells 
(non-toxic concentration of 4 to cells is 9.78 uM). dugesin F (4) 
was the only one exhibiting inhibitory effect on influenza virus 
FM1 strain causing CPE in MDCK cells. This isolates at 31.25 
μg/mL completely inhibited influenza virus FM1 strain in HI 
test. TC50 value and IC50 value of this compound determined 
by MTT assay were 45.67 μg/mL and 9.43 μg/mL, respective-
ly. Corresponding therapeutic index (TI) was 4.84, implying 
dugesin F (4) a non-toxic antiviral compound.  
Considering the fact that clerodane diterpenoids have re-
ported as a rich source of natural insect antifeedants,18 the 
antifeedant activity of the four major constituents tilifodiolide, 
compound 1, isosalvipuberulin, and salviandulin E was also 
evaluated. The result indicated that dugesin E and isosalvipu-
berulin exhibited weak anti-feedant activities with AI (anti-
feedant index, %) of 6.49 and 14.94, respectively. Tilifodi-
olide and salviandulin E had no anti-feedant activity at all. 
Instead, they can improve the Pseudaletia separata Walker to 




General Experimental Procedures. Optical rotations were 
measured with a Horiba SEPA-300 polarimeter. Ultraviolet 
absorption spectra were recorded on a UV-2401 PC spectro-
photometer. IR spectra were obtained from a Bio-Rad FtS-135 
spectrometer. NMR spectra were measured on a Bruker AV-
400 spectrometer with TMS as the internal standard, while 2D 
NMR spectra were recorded by using a Bruker DRX-500 
NMR instrument. EIMS were obtained on a VG Auto Spec-
3000 spectrometer (70 eV). ESIMS and HRESIMS were taken 
on an API Qstar Pulsar instrument. Column chromatography 
was performed on silica gel and silica gel H (200–300 mesh, 
10–40 μm, Qingdao Marine Chemical Inc. China). Lichroprep 
RP-18 (43–63 μm, Merck, Darmstadt, Germany), Sephadex 
LH-20 (Pharmacia Fine Chemical Co. Ltd.), and DM-130 
(macroporous resin, Baoen Co. Ltd.) were also used for col-
umn chromatography. An Agilent 1100 series instrument 
equipped with Alltima C18 column (4.6 × 250 mm) was used 
for HPLC analysis and a preparative Alltima C18 column (22 × 
250 mm) was used in the sample preparation. Fractions were 
monitored by TLC and spots were visualized by heating silica 
gel plates sprayed with 10% H2SO4 in EtOH. 
 
Plant Material. Leaves and stems of S. dugesii Fernald 
were collected in Kunming, Yunnan, China, in August, 2006, 
and were identified by Prof. Xi-Wen Li of the Kunming insti-
tute of Botany, the Chinese Academy of Sciences, China. A 
voucher specimen, 2006218, was deposited in the State Key 
Laboratory of Phytochemistry and Plant Resources in West 
China, Kunming Institute of Botany, Chinese Academy of 
Sciences. 
 
Extraction and Isolation. The dried and powdered (8.8 kg) 
S. dugesii Fernald were extracted with Me2CO for three times 
(4 × 40 L, each 3 days) at room temperature and filtered. The 
solvent was removed under vacuum. The gummy residue (310 
g) was subjected to column chromatography over DM-130 
porous resin and eluted with MeOH-H2O (50% and 90%). The 
residue of 90% MeOH-H2O fraction was partitioned between 
H2O and EtOAc. The EtOAc part (210 g) was subjected to 
column chromatography over silica gel. Mixtures of petroleum 
ether-Me2CO of increasing polarity were used as eluents. Five 
fractions were collected and combined by monitoring with 
TLC. Tilifodiolide (27.5 g) was crystallized from the second 
fraction. The mother liquor of the second fraction was chro-
matographed on a silica gel column (petroleum ether-CHCl3-
EtOAc, 4:4:2) and sephadex LH-20 (CH3Cl-MeOH, 1:1) to 
give compound 1 (78 mg), dugesin A (8 mg), and isosalvipu-
berulin (645 mg). Fraction 3 was repeatedly chromatographed 
over lichroprep RP-18 eluted by MeOH-H2O (from 5:5 to 1:0) 
and silica gel (petroleum ether-Me2CO, 94:6) to give com-
pound 3 (10 mg) and salvifaricin (9 mg). Fraction 4 was chro-
matographed on lichroprep RP-18 (MeOH-H2O, from 65:35 to 
100:0) to afford three sub-fractions, 3a−3c. Sub-fraction 3a 
was subjected to column chromatography on silica gel using 
petroleum ether-Me2CO (9:1) as eluent to yield the crude 
compounds 2 (8 mg), 4 (6 mg), dugesin B (4 mg), and salvian-
dulin E (18 mg), which was purified by sephadex LH-20 
(CH3Cl-MeOH, 1:1) and preparative HPLC (MeOH-H2O, 9:1). 
Sub-fraction 3b was further purified by Sephadex LH-20 
(CH3Cl-MeOH, 1:1) and preparative HPLC (MeOH-H2O, 
85:15) to afford compound 5 (2 mg). 
 
Dugesin C (1): white powder; [α]22D − 32.4 (c 0.40, CHCl3). 
Table 3. Antifeedant activities of the isolates with AI (antifeedant index, %) at 500 ppm. 
 
compound 
feeding area (mm2) average feeding 
area (mm2) 
 
AI 1 2 3 4 5 6 7 8 9 10
dugesin E 144 290 302 330 289 212 311 336 257 207 267.8 6.49
isosalvipuberulin 234 252 263 273 279 225 249 301 262 98 243.6 14.94
tilifodiolide 356 353 348 339 343 357 370 355 323 376 352 − 22.91 
salviandulin E 260 293 243 293 308 358 348 366 339 312 312 − 8.94 
CK 215 295 245 281 325 296 313 286 270 338 286.4 0 
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IR (KBr) υmax 2923, 1754, 1682, 1657, 1504, 1432, 1420, 1207, 
1190, 1019, 957, 874, 752 cm−1. UV (CHCl3) λmax (log ε) 
256.2 (1.54) nm. 1H (CDCl3, 400MHz) and 13C NMR (CDCl3, 
100MHz) spectral data, see Tables 1 and 2. EIMS m/z 338 
[M]+ (12), 320 (14), 292 (20), 270 (41), 220 (100), 228 (45), 
195 (59), 161 (100), 153 (44) , 141 (56), 128 (84), 115 (73), 
95 (69). Positive HRESIMS m/z 339.1230 [M + H]+, (calcd. 
for C20H19O5, 339.1233). 
 
Dugesin D (2): white powder; [α]22D − 228.5 (c 0.43, CHCl3).  
IR (KBr) υmax 3436, 2927, 1755, 1675, 1504, 1432, 1304, 1262, 
1192, 1164, 1026, 994, 875 cm−1. UV (CHCl3) λmax (log ε) 
256.2 (1.08), 239.4 (1.19) nm. 1H (C5D5N, 400Hz) and 13C 
NMR (C5D5N, 100Hz) spectral data, see Tables 1 and 2. EIMS 
m/z 356 [M]+ (9), 338 (9), 326 (76), 308 (14), 280 (16), 220 
(100), 191 (72), 176 (26), 145 (24), 95 (40). Positive 
HRESIMS m/z 379.1153 [M + Na]+, (calcd. for C20H20O6Na, 
379.1157). 
 
Dugesin E (3):  white powder; [α]22D − 41.0 (c 0.41, CHCl3).  
IR (KBr) υmax 2956, 1768, 1662, 1504, 1432, 1375, 1288, 1237, 
1196, 1147, 1024, 873 cm−1. UV (CHCl3) λmax (log ε) 268.8 
(0.44), 239.6 (0.65) nm. 1H (CDCl3, 400Hz) and 13C NMR 
(CDCl3, 100Hz) spectral data, see Tables 1 and 2. EIMS m/z 
400 [M]+ (16), 358 (6), 340 (6), 256 (24), 219 (36), 203 (86), 
135 (63), 95 (81), 82 (100). Positive HRESIMS m/z 423.1420 
[M + Na]+, (calcd. for C22H24O7Na, 423.1419). 
 
Dugesin F (4): white powder; [α]22D − 26.1 (c 0.08, CHCl3).  
IR (KBr) υmax 3432, 2923, 1754, 1712, 1631, 1503, 1458, 1341, 
1261, 1229, 1038, 1008, 969, 874 cm−1. UV (CHCl3) λmax (log ε) 275.4 (1.45), 239.0 (1.39) nm. 1H (CDCl3, 400Hz) and 13C 
NMR (acetond-d6, 100Hz) spectral data, see Tables 1 and 2. 
EIMS: m/z 356 [M]+ (3), 338 (11), 267 (12), 239 (18), 203 
(12), 185 (13), 165 (13), 134 (22), 128 (20), 115 (28), 108 (87), 
95 (49), 94 (100), 81 (43). Positive HRESIMS m/z 379.1164 
[M + Na]+, (calcd. for C20H20O6Na, 379.1157). 
 
Dugesin G (5): white powder; [α]22D − 88.9 (c 0.02, CHCl3).  
IR (KBr) υmax 3455, 2916, 1769, 1725, 1670, 1504, 1557, 1364, 
1268, 1229, 1039, 1018, 979, 874 cm−1. UV (CHCl3) λmax (log ε) 240.8 (0.96), 230.0 (0.80) nm. 1H (CDCl3, 400MHz) and 13C 
NMR (CDCl3, 100MHz) spectral data, see Tables 1 and 2. 
EIMS: m/z 356 (M+, 2), 338 (13), 310 (9), 246 (15), 216 (11), 
201 (25), 171 (12), 157 (20), 143 (34), 128 (19), 110 (100), 95 
(45). Positive HRESIMS m/z 379.1165 [M + Na]+, (calcd. for 
C20H20O6Na, 379.1157). 
 
Anti-Viral Bioassay. Anti-viral activity was tested using 
cytopathic effect (CPE) reduction assay and hemagglutination 
(HI) in influenza virus FM1 strain infected dog kidney cell 
line MDCK by referring method described previously.19 
Briefly, virus infected MDCK cells were treated with different 
concentrations of sample. A known antiviral agent virazole 
was used as positive control. Drug treatment lasted for 4 d. 
The CPE was examined and counted and the concentration 
that reduced CPE by 50% was recorded as IC50. The media 
were checked by HI test for virus caused blood clotting. Virus 
uninfected MDCK cells were treated the same for 
determination of TC50 (concentration of sample causing 50% 
of cell death). Therapeutic index (TI) of sample is calculated 
from the ratio of TC50/IC50. A drug that has a TI > 2 is thought 
to be an effective virus inhibitor and be non-toxic. While in HI 
test, an effective virus inhibitor should inhibit the formation of 
blood clot. 
 
Cytotoxic Bioassay. The cytotoxicity of selected isolates 
against HepG2, CNE, Hela and NCI-H460 cell lines was in-
vestigated using MTT assay.20 Concentration of a compound 
inhibiting 50% of cell growth (IC50) of each compound was 
calculated by the Reed and Muench method. Solvent and blank 
were included in experiments.21 
 
Antifeedant Bioassay. The tested samples were dissolved 
in acetone and diluted to 500 ppm using 0.1% Triton X-100 in 
water. The fresh leaves of Vicia faba L. were cut into small 
holes of 189 mm2 area by a puncher. The cotyledon leaves 
were dipped into different sample solutions for 3 seconds, and 
air dried. Solvent control (0.1% Triton X-100 in water) was 
used as an untreated group. The antifeedant experiments were 
then carried out by a modified leaf-disk choice test.22 After the 
third-instar Pseudaletia separate, Walker was starved for 3 h, 
it was put into a Petri dish with two treated and untreated coty-
ledon leaves and allowed to feed for 24 h. Ten replicates were 
used for each treatment. 
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